Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arya Pharmaceutical, commonly known as Arya Darou, is a prominent private pharmaceutical manufacturer headquartered in Tehran, Iran. Established in 2002, the company specializes in the development and production of a wide array of generic medicines, with a primary focus on oral solid dosage forms such as tablets and capsules. Its diverse product portfolio addresses significant therapeutic areas, including cardiovascular health, central nervous system disorders, and metabolic diseases like diabetes. The company operates modern manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards to ensure the highest quality of its pharmaceutical products. Arya Pharmaceutical serves as a critical supplier to the Iranian healthcare system and actively exports its products to regional markets in the Middle East and Central Asia. By focusing on affordability and therapeutic efficacy, the company plays a vital role in enhancing patient access to essential medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arya Pharm.